Lung Cancer News and Research

Latest Lung Cancer News and Research

New pathologic scoring system could help predict survival in lung cancer patients

A new pathologic scoring system that accurately assesses how much lung tumor is left after a patient receives presurgical cancer treatments can be used to predict survival, according to new research led by investigators at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center and the Mark Foundation Center for Advanced Genomics and Imaging at the Johns Hopkins University.

6 Nov 2023

Tobacco smoking undermines anti-cancer safeguards by causing harmful DNA mutations

Scientists at the Ontario Institute for Cancer Research (OICR) have uncovered one way tobacco smoking causes cancer and makes it harder to treat by undermining the body's anti-cancer safeguards.

3 Nov 2023

New smart data concept to help patients with internal diseases get more active and live better lives

Establishing a digital assistance system based on artificial intelligence to support patients / Sports Medicine research group of Mainz University involved in two projects coordinated by the Mainz University Medical Center.

2 Nov 2023

New drug shows promise in killing cancer cells with genetic vulnerability

Imagine the body's cells are well-behaved students in the classroom. The "teachers" are tumor suppressor genes, and they make sure cells follow the rules. But when tumor suppressor genes are away, cells may go astray.

1 Nov 2023

New lung cancer screening guideline expands eligibility to save more lives

Today, the American Cancer Society (ACS) released an update of its lung cancer screening guideline to help reduce the number of people dying from the disease due to smoking history.

1 Nov 2023

Study unveils new approach to more precise, long-lasting, and less toxic cancer treatment

For too long, cancer treatment has been a double-edged sword – the very treatments designed to kill cancer cells often wrought havoc on healthy ones too.

30 Oct 2023

Dato-DXd improves progression-free survival in patients with metastatic non-squamous NSCLC

Treatment with datopotamab deruxtecan (Dato-DXd), a novel Trop-2 directed antibody-drug conjugate, was found to significantly improve progression-free survival in patients with metastatic non-small cell lung cancer, an improvement that was primarily driven by patients with non-squamous tumors.

26 Oct 2023

Healthy eating may be a key player in COPD risk reduction

The association between diet quality and the odds of Chronic obstructive pulmonary disease (COPD).

26 Oct 2023

Study finds link between industry payments to oncologists and non-recommended cancer treatments

Patients with cancer whose oncologist receives payments from industry appear more likely to receive some non-recommended and low value treatments, finds a US study published by The BMJ today.

25 Oct 2023

Blood test detects cancer earlier in individuals with Li-Fraumeni syndrome

Researchers from The Hospital for Sick Children (SickKids), the Ontario Institute for Cancer Research (OICR) and University Health Network (UHN) have demonstrated that by analyzing patients' blood samples, they are able to detect cancer earlier in individuals with Li-Fraumeni syndrome, an inherited condition with an almost 100 percent life-time risk of developing cancer.

24 Oct 2023

Perioperative durvalumab may change standard-of-care for patients with resectable lung cancer

A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete response (pCR) rates compared to chemotherapy alone for patients with operable non-small cell lung cancer (NSCLC), according to results of a Phase III trial reported by researchers at The University of Texas MD Anderson Cancer Center.

24 Oct 2023

Utilizing Biomarkers in Cancer Prevention, Diagnosis, and Treatment

In this interview, Grace Liu from Sino Biological discusses the crucial role of biomarkers in cancer prevention and diagnosis and how they can help guide treatment decisions.

From Sino Biological Inc. 24 Oct 2023

Lactobacillus iners in tumors: Driving chemoradiation resistance via lactate-induced metabolic rewiring

Investigating tumor and gut microbiome traits that impact chemoradiation therapy in patients with cervical cancer.

24 Oct 2023

Perioperative immunotherapy improves event-free survival in resectable early-stage lung cancer

Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery – significantly improved event-free survival (EFS) in patients with resectable early-stage non-small cell lung cancer (NSCLC).

22 Oct 2023

Association between lung cancer risk and adherence to dietary patterns

The association between different “a posteriori” (data-driven) diets and the risk of lung cancer.

19 Oct 2023

Lung chip model offers new insights into how radiation damages the lungs

The lung is one of the tissues most sensitive to radiation in the human body. People exposed to high radiation doses following nuclear incidents develop radiation-induced lung injury (RILI), which affects the function of many cell types in the lung, causing acute and sustained inflammation, and in the longer term, the thickening and scarring of lung tissue known as fibrosis.

17 Oct 2023

Air pollution linked to increased breast cancer risk in women

Women living and working in places with higher levels of fine particle air pollution are more likely to get breast cancer than those living and working in less polluted areas.

17 Oct 2023

New treatment options offer hope for patients with non-small cell lung cancer

More people with non-small cell lung cancer (NSCLC) are likely to benefit from new drugs that target molecular alterations in tumour cells, with less need for chemotherapy, following results of multiple landmark clinical trials reported for the first time in late-breaking presentations at the ESMO Congress 2023 (1-7).

17 Oct 2023

Moffitt Cancer Center researchers identify hidden target of ROS1 inhibitor lorlatinib

Targeted cancer drugs are widely used because of their ability to inhibit specific proteins involved in cancer development with fewer side effects compared to chemotherapy drugs.

16 Oct 2023

UCLA receives grant to improve liquid biopsy for early lung cancer detection

A team of investigators from the UCLA Jonsson Comprehensive Cancer Center and the UCLA School of Dentistry received a five-year $4.6 million grant from the National Cancer Institute to develop and improve liquid biopsy technologies for the early detection of lung cancer -; the leading cause of cancer death in both men and women in the U.S.

13 Oct 2023

Lung Cancer News and Research

Latest Lung Cancer News and Research

New pathologic scoring system could help predict survival in lung cancer patients

Tobacco smoking undermines anti-cancer safeguards by causing harmful DNA mutations

New smart data concept to help patients with internal diseases get more active and live better lives

New drug shows promise in killing cancer cells with genetic vulnerability

New lung cancer screening guideline expands eligibility to save more lives

Study unveils new approach to more precise, long-lasting, and less toxic cancer treatment

Dato-DXd improves progression-free survival in patients with metastatic non-squamous NSCLC

Healthy eating may be a key player in COPD risk reduction

Study finds link between industry payments to oncologists and non-recommended cancer treatments

Blood test detects cancer earlier in individuals with Li-Fraumeni syndrome

Perioperative durvalumab may change standard-of-care for patients with resectable lung cancer

Utilizing Biomarkers in Cancer Prevention, Diagnosis, and Treatment

Lactobacillus iners in tumors: Driving chemoradiation resistance via lactate-induced metabolic rewiring

Perioperative immunotherapy improves event-free survival in resectable early-stage lung cancer

Association between lung cancer risk and adherence to dietary patterns

Lung chip model offers new insights into how radiation damages the lungs

Air pollution linked to increased breast cancer risk in women

New treatment options offer hope for patients with non-small cell lung cancer

Moffitt Cancer Center researchers identify hidden target of ROS1 inhibitor lorlatinib

UCLA receives grant to improve liquid biopsy for early lung cancer detection

How medical manufacturing trends are evolving: From performance testing to 3D vision

Utilizing firefly liquid handling for laboratory developed tests

Immunopeptidomics offer new hope in cancer research

Lung Cancer News and Research

Latest Lung Cancer News and Research

How medical manufacturing trends are evolving: From performance testing to 3D vision

Utilizing firefly liquid handling for laboratory developed tests

Immunopeptidomics offer new hope in cancer research

Newsletters you may be interested in